119 related articles for article (PubMed ID: 22996619)
1. Metabolic syndrome in psychiatrically hospitalized patients treated with antipsychotics and other psychotropics.
Centorrino F; Masters GA; Talamo A; Baldessarini RJ; Öngür D
Hum Psychopharmacol; 2012 Sep; 27(5):521-6. PubMed ID: 22996619
[TBL] [Abstract][Full Text] [Related]
2. Changes in medication practices for hospitalized psychiatric patients: 2009 versus 2004.
Centorrino F; Ventriglio A; Vincenti A; Talamo A; Baldessarini RJ
Hum Psychopharmacol; 2010 Mar; 25(2):179-86. PubMed ID: 20196186
[TBL] [Abstract][Full Text] [Related]
3. Hospital use of antipsychotic drugs: polytherapy.
Centorrino F; Cincotta SL; Talamo A; Fogarty KV; Guzzetta F; Saadeh MG; Salvatore P; Baldessarini RJ
Compr Psychiatry; 2008; 49(1):65-9. PubMed ID: 18063043
[TBL] [Abstract][Full Text] [Related]
4. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
[TBL] [Abstract][Full Text] [Related]
5. Cardiometabolic comorbidity in antipsychotic treated patients: need for systematic evaluation and treatment.
Steylen PM; van der Heijden FM; Kok HD; Sijben NA; Verhoeven WM
Int J Psychiatry Clin Pract; 2013 Jun; 17(2):125-30. PubMed ID: 23437800
[TBL] [Abstract][Full Text] [Related]
6. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
7. [Prevalence and type of dermatologic disorders in psychiatric patients treated with psychotropic drugs].
Murak-Kozanecka E; Rabe-Jabłońska J
Psychiatr Pol; 2004; 38(3):491-505. PubMed ID: 15199658
[TBL] [Abstract][Full Text] [Related]
8. Antipsychotic drug use: McLean Hospital, 2002.
Centorrino F; Fogarty KV; Sani G; Salvatore P; Cimbolli P; Baldessarini RJ
Hum Psychopharmacol; 2005 Jul; 20(5):355-8. PubMed ID: 15957153
[TBL] [Abstract][Full Text] [Related]
9. Psychotropic drug use in older people with mental illness with particular reference to antipsychotics: a systematic study of tolerability and use in different diagnostic groups.
Curran S; Turner D; Musa S; Wattis J
Int J Geriatr Psychiatry; 2005 Sep; 20(9):842-7. PubMed ID: 16116576
[TBL] [Abstract][Full Text] [Related]
10. [Pharmaco-therapeutic evaluation of medical treatments of adult autistics and multi-handicapped patients in a public mental health unit].
Armand-Branger S; Poisson N; Gaudoneix-Taïeb M; Ramos O
Encephale; 2009 Sep; 35(4):370-6. PubMed ID: 19748374
[TBL] [Abstract][Full Text] [Related]
11. Assessment of a point-of-care metabolic risk screening program in outpatients receiving antipsychotic agents.
Schneiderhan ME; Batscha CL; Rosen C
Pharmacotherapy; 2009 Aug; 29(8):975-87. PubMed ID: 19637951
[TBL] [Abstract][Full Text] [Related]
12. Use of combinations of antipsychotics: McLean Hospital inpatients, 2002.
Centorrino F; Fogarty KV; Sani G; Salvatore P; Cincotta SL; Hennen J; Guzzetta F; Talamo A; Saadeh MG; Baldessarini RJ
Hum Psychopharmacol; 2005 Oct; 20(7):485-92. PubMed ID: 16116665
[TBL] [Abstract][Full Text] [Related]
13. Metabolic syndrome and mental illness.
Newcomer JW
Am J Manag Care; 2007 Nov; 13(7 Suppl):S170-7. PubMed ID: 18041878
[TBL] [Abstract][Full Text] [Related]
14. Metabolic risk status and second-generation antipsychotic drug selection: a retrospective study of commercially insured patients.
Morrato EH; Cuffel B; Newcomer JW; Lombardo I; Kamat S; Barron J
J Clin Psychopharmacol; 2009 Feb; 29(1):26-32. PubMed ID: 19142103
[TBL] [Abstract][Full Text] [Related]
15. [Clinical factors related to gains in body mass index (BMI) among patients under long-term antipsychotic treatment].
Koga M
Seishin Shinkeigaku Zasshi; 2003; 105(4):473-88. PubMed ID: 12806910
[TBL] [Abstract][Full Text] [Related]
16. The metabolic syndrome in an Italian psychiatric sample: a retrospective chart review of inpatients treated with antipsychotics.
Santini I; Stratta P; D'Onofrio S; De Lauretis I; Santarelli V; Pacitti F; Rossi A
Riv Psichiatr; 2016; 51(1):37-42. PubMed ID: 27030348
[TBL] [Abstract][Full Text] [Related]
17. Prevalence, utilization patterns, and predictors of antipsychotic polypharmacy: experience in a multistate Medicaid population, 1998-2003.
Morrato EH; Dodd S; Oderda G; Haxby DG; Allen R; Valuck RJ
Clin Ther; 2007 Jan; 29(1):183-95. PubMed ID: 17379060
[TBL] [Abstract][Full Text] [Related]
18. Cost-effective screening for the metabolic syndrome in patients treated with second-generation antipsychotic medications.
Straker D; Correll CU; Kramer-Ginsberg E; Abdulhamid N; Koshy F; Rubens E; Saint-Vil R; Kane JM; Manu P
Am J Psychiatry; 2005 Jun; 162(6):1217-21. PubMed ID: 15930076
[TBL] [Abstract][Full Text] [Related]
19. Hospitalization risk associated with typical and atypical antipsychotic use in community-dwelling elderly patients.
Aparasu RR; Jano E; Johnson ML; Chen H
Am J Geriatr Pharmacother; 2008 Oct; 6(4):198-204. PubMed ID: 19028375
[TBL] [Abstract][Full Text] [Related]
20. Improved body weight and metabolic outcomes in overweight or obese psychiatric patients switched to amisulpride from other atypical antipsychotics.
Lin CC; Bai YM; Wang YC; Chen TT; Lai IC; Chen JY; Chen SY; Gau SS; Liou YJ
J Clin Psychopharmacol; 2009 Dec; 29(6):529-36. PubMed ID: 19910716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
